Medicine and Dentistry
COVID-19
100%
Cohort Analysis
94%
Intensive Care
88%
Intensive Care Unit
77%
Critical Illness
53%
Prevalence
31%
Observational Study
29%
Systematic Review
25%
Comorbidity
22%
Frailty
21%
Odds Ratio
21%
Multiple Chronic Conditions
21%
Artificial Respiration
19%
Health Care Cost
19%
Retrospective Cohort Study
19%
Dyspnea
18%
Sepsis
18%
Medicine
17%
Cohort Study
17%
Prospective Cohort Study
16%
Influenza Vaccine
16%
Diseases
16%
Primary Health Care
15%
Infection
15%
Gene Linkage
13%
Influenza Vaccination
13%
Hazard Ratio
13%
Clonidine
13%
Dexmedetomidine
13%
Propofol
13%
Hospital Mortality
12%
Emergency Care
12%
Quality of Life
12%
Diabetes
12%
Cohort Effect
11%
Randomized Controlled Trial
11%
Resuscitation
11%
Acute Disease
11%
Logistic Regression Analysis
11%
Cardiovascular Disease
10%
Emergency Department
10%
Disease Severity
9%
Cost-Effectiveness Analysis
9%
National Health Service
8%
Postcovid Syndrome
8%
Mental Health
8%
Post-COVID-19
8%
General Medicine
8%
Renal Replacement Therapy
8%
Health Outcomes
8%
Nursing and Health Professions
Cohort Analysis
69%
Intensive Care
53%
Intensive Care Unit
53%
Systematic Review
33%
Critical Illness
31%
Frailty
22%
Prevalence
21%
Hospital Readmission
20%
Artificial Respiration
19%
Sedation
19%
Hospital Discharge
18%
Sepsis
16%
Diseases
13%
Prospective Cohort Study
13%
Dyspnea
13%
Propofol
13%
Clonidine
12%
Dexmedetomidine
12%
Comorbidity
12%
Quality of Life
12%
Heart Arrest
11%
Mental Health
11%
Cardiovascular Disease
10%
Treatment Outcome
9%
Logistic Regression Analysis
9%
Confidence Interval
9%
Acute Disease
8%
Clinical Audit
8%
Cost Effectiveness Analysis
8%
Renal Replacement Therapy
8%
Cross-Sectional Study
7%
Umbrella Review
7%
Influenza Vaccine
7%
Biological Marker
7%
Health Outcomes
7%
C Reactive Protein
7%
Home Care
7%
Socialized Medicine
7%
Emergency Care
7%
Geriatric Assessment
7%
Infection
6%
Primary Medical Care
6%
Cognitive Defect
6%
Length of Stay
6%
Hazard Ratio
5%
Health Care Utilization
5%
Kidney Graft
5%
Odds Ratio
5%
Health Care Personnel
5%
Professional Standard
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
52%
Diseases
25%
Coronavirinae
19%
Critical Illness
19%
Prevalence
18%
Case-Control Study
15%
Clonidine
14%
Comorbidity
14%
Dexmedetomidine
14%
Frailty
12%
Replacement Therapy
11%
Infection
11%
Observational Study
11%
Propofol
11%
Dyspnea
9%
Maternal Morbidity
7%
Polypharmacy
7%
Cardiovascular Disease
7%
Multiple Chronic Conditions
7%
Randomized Clinical Trial
7%
Prospective Cohort Study
6%
Disease Severity
6%
Cognitive Defect
5%
Respiratory Tract Disease
5%
Asthma
5%
Delirium
5%
Hospital Mortality
5%
